1. SarlesH, SarlesJC, MuratoreR, et al.Chronic inflammatory sclerosis of the pancreas – an autonomous pancreatic disease?Am J Dig Dis1961;6:688. CrossRef

2. ChariST, SingerMV. The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol1994;29:949. CrossRef

3. YoshidaK, TokiF, TakeuchiT, et al.Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci1995;40:1561. CrossRef

4. HamanoH, KawaS, HoriuchiA, et al.High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med2001;344:732. CrossRef

5. UmeharaH, OkazakiK, MasakiY, et al.A novel clinical entity, IgG4‐related disease (IgG4RD): general concept and details. Mod Rheumatol2012;22:1. CrossRef

6. HartPA, KamisawaT, BruggeWR, et al.Long‐term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut2013;62:1771. CrossRef

7. UchidaK, MasamuneA, ShimosegawaT, et al.Prevalence of IgG4‐related disease in Japan based on nationwide survey in 2009. Int J Rheumatol2012;2012:358371.

8. WolfsonD, BarkinJS, ChariST, et al.Management of pancreatic masses. Pancreas2005;31:203. CrossRef

9. AalberseRC, StapelSO, SchuurmanJ, et al.Immunoglobulin G4: an odd antibody. Clin Exp Allergy2009;39:469. CrossRef

10. StoneJH, ZenY, DeshpandeV. IgG4‐related disease. N Engl J Med2012;366:539. CrossRef

11. HartPA, TopazianMD, WitzigTE, et al.Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut2013;62:1607. CrossRef

12. KawaS, OtaM, YoshizawaK, et al.HLA DRB10405‐DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology2002;122:1264. CrossRef

13. Park doH, KimMH, OhHB, et al.Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology2008;134:440. CrossRef

14. ZenY, BogdanosDP, KawaS. Type 1 autoimmune pancreatitis. Orphanet J Rare Dis2011;6:82. CrossRef

15. FrulloniL, LunardiC, SimoneR, et al.Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med2009;361:2135. CrossRef

16. KamisawaT, ChariST, GidaySA, et al.Clinical profile of autoimmune pancreatitis and its histological subtypes: an international multicenter survey. Pancreas2011;40:809. CrossRef

17. OtsukiM, ChungJB, OkazakiK, et al.Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan‐Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol2008;43:403. CrossRef

18. ChariST, SmyrkTC, LevyMJ, et al.Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol2006;4:1010, quiz 934. CrossRef

19. ShimosegawaT, ChariST, FrulloniL, et al.International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas2011;40:352. CrossRef

20. ZhangL, ChariS, SmyrkTC, et al.Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria. Pancreas2011;40:1172. CrossRef

21. ChariST, TakahashiN, LevyMJ, et al.A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol2009;7:1097. CrossRef

22. BodilyKD, TakahashiN, FletcherJG, et al.Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. Am J Roentgenol2009;192:431. CrossRef

23. MoonSH, KimMH, ParkDH, et al.Is a 2‐week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut2008;57:1704. CrossRef

24. SugumarA, LevyMJ, KamisawaT, et al.Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut2011;60:666. CrossRef

25. HiranoK, KawabeT, YamamotoN, et al.Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta2006;367:181. CrossRef

26. MaireF, Le BaleurY, ReboursV, et al.Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol2011;106:151. CrossRef

27. RyuJK, ChungJB, ParkSW, et al.Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study. Pancreas2008;37:377. CrossRef

28. SahRP, ChariST, PannalaR, et al.Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology2010;139:140, quiz e12‐3. CrossRef

29. SongTJ, KimMH, MoonSH, et al.The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone. Am J Gastroenterol2010;105:1655. CrossRef

30. BjornssonE, ChariS, SilveiraM, et al.Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy. Am J Ther2011;18:198. CrossRef

31. ChoiEK, KimMH, LeeTY, et al.The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas2007;35:156. CrossRef

32. GhazaleA, ChariST, SmyrkTC, et al.Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol2007;102:1646. CrossRef

33. MendesFD, JorgensenR, KeachJ, et al.Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol2006;101:2070. CrossRef

34. OseiniAM, ChaiteerakijR, ShireAM, et al.Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4‐associated cholangitis from cholangiocarcinoma. Hepatology2011;54:940. CrossRef

35. RainaA, KrasinskasAM, GreerJB, et al.Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med2008;132:48.

36. SandanayakeNS, ChurchNI, ChapmanMH, et al.Presentation and management of post‐treatment relapse in autoimmune pancreatitis/ immunoglobulin G4‐associated cholangitis. Clin Gastroenterol Hepatol2009;7:1089. CrossRef

37. KamisawaT, ShimosegawaT, OkazakiK, et al.Standard steroid treatment for autoimmune pancreatitis. Gut2009;58:1504. CrossRef

38. NaitohI, NakazawaT, HayashiK, et al.Clinical differences between mass‐forming autoimmune pancreatitis and pancreatic cancer. Scand J Gastroenterol2012;47:607. CrossRef

39. TakahashiN, FletcherJG, HoughDM, et al.Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual‐phase CT. AJR Am J Roentgenol2009;193:479. CrossRef

40. HiranoK, TadaM, IsayamaH, et al.Long‐term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut2007;56:1719. CrossRef

41. ZamboniG, LuttgesJ, CapelliP, et al.Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch2004;445:552. CrossRef

42. GhazaleA, ChariST, ZhangL, et al.Immunoglobulin G4‐associated cholangitis: clinical profile and response to therapy. Gastroenterology2008;134:706. CrossRef

43. FrulloniL, ScattoliniC, FalconiM, et al.Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol2009;104:2288. CrossRef

44. KamisawaT, OkazakiK, KawaS, et al.Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol2010;45:471. CrossRef

45. GhazaleA, ChariST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut2007;56:1650. CrossRef

46. TopazianM, WitzigTE, SmyrkTC, et al.Rituximab therapy for refractory biliary strictures in immunoglobulin G4‐associated cholangitis. Clin Gastroenterol Hepatol2008;6:364. CrossRef

47. HartPA, LawRJ, DierkhisingRA, et al.Risk of cancer in autoimmune pancreatitis: a case‐control study and review of the literature. Pancreas2014;43:417. CrossRef

48. KhosroshahiA, CarruthersMN, DeshpandeV, et al.Rituximab for the treatment of IgG4‐related disease: lessons from 10 consecutive patients. Medicine2012;91:57. CrossRef

49. ShiokawaM, KodamaY, YoshimuraK, et al.Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol2013;108:610. CrossRef

50. EctorsN, MailletB, AertsR, et al.Non‐alcoholic duct destructive chronic pancreatitis. Gut1997;41:263. CrossRef

51. NotoharaK, BurgartLJ, YadavD, et al.Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol2003;27:1119. CrossRef

52. DeshpandeV, GuptaR, SainaniN, et al.Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol2011;35:26. CrossRef

53. ChariST, KloeppelG, ZhangL, et al.Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas2010;39:549. CrossRef